[Chronic necrotizing pulmonary aspergillosis and ankylosing spondylarthritis]. / Aspergillose pulmonaire nécrosante chronique et spondylarthrite ankylosante.

Fibro-bullous disease is a late complication of ankylosing spondylarthritis. Its radiologic features frequently mimics tuberculosis or excavated neoplasm. About 50 to 65% of patients with ankylosing spondylarthritis have chronic aspergillus colonization of their airways. Pulmonary aspergillosis infection occurs in 10 to 30% during evolution. We report two cases of patients with spondylarthritis who developed chronic necrotizing pulmonary aspergillosis. Diagnosis was based on serology, mycologic examination of expectoration and in one case on histology obtain by transbronchial biopsies. Pulmonary complications due to aspergillus species frequently reveal an associated fibro-bullous disease in patients with ankylosing spondylarthritis. This can be reported to diminished chest wall movements in such patients. Treatment is based on administration of anti-fungal drugs. In case of medical treatment failure, thoracic surgery may be indicated.

[Allergologic diagnosis]. / Le diagnostic allergologique.

There are two phases in allergologic diagnosis of respiratory diseases related to immediate hypersensitivity reactions: establishment of the allergic origin of the symptoms and identification of the causal allergen or allergens. In addition to the basic information obtained from history taking and physical examination, prick tests provide an easy, rapid, and low cost means of correctly identifying specific allergens. Laboratory tests such as serum assay of specific IgE can be useful when history and prick tests provide conflicting information, in exceptional cases when prick tests cannot be performed, or when specific desensitization is indicated. IgE assay is however of little use if prick tests are negative or clinical history poorly suggestive. The role of screening for atopy using multiple-allergen prick tests which give a global positive or negative result is poorly defined. Screening tests would be interesting if symptoms suggest, among other hypotheses, an allergic disease, especially if prick tests cannot be performed rapidly. Other atopy tests, such as total serum IgE, have little use. Finally, specific provocation tests are rarely needed for routine allergologic diagnosis. They may be useful in complex clinical situations or in particular conditions such as occupational allergy.

[Results of 248 patients with sleep apnea syndrome treated by continuous positive pressure ventilation between 1990 and 1995. A study of compliance and outcome of the apnea-hypopnea index]. / Suivi de 248 patients présentant un syndrome d'apnée du sommeil traités par pression positive continue entre 1990 et 1995. Etude de l'observance et du devenir de l'index d'apnée-hypopnée.

Between 1990 and 1995, 369 patients were investigated for obstructive sleep apnea syndrome (OSAS) by polysomnography. Among them, 248 patients with a mean Apnea-Hyponea index (AHI) of 37.7 per hour were treated by nasal continuous positive airway pressure (n-CPAP). Mean follow up was 39.5 +/- 20.4 months. In this group, 23 patients (9.2%) refused nCPAP immediately or after the first night and 39 (15.7%) gave up later. 15 patients (6%) died during the period of the study. The cumulative compliance reached 70% at 72 months. Non compliant patients usually gave up n-CPAP before the end of the first year. We compared the group of 150 patients always treated at the date of 31/12/95 with the group of 62 patients who refused nCPAP initially or gave up later. There was no difference in clinical parameters or polysomnographic data between the two groups. In 94 patients treated by nCPAP for more than a year we evaluated the outcome of AHI by a polysomnography performed after 72 hours of nCPAP cessation. Mean AHI of the group at this time was 38.2 +/- 20.3/h and was well correlated with the initial index (r = 0.41, p < 0.0001). However for 28 patients (29.7%) we observed, at the time of this second AHI determination, a variation (plus or minus) of at least 50% of the index. 6 patients, without any significative weigth loss, had an AHI below 5/h at this second determination. In this small group nCPAP was interrupted for 6 to 12 months, then another polysomnography was performed. At this time mean AHI was 42.4/h and clinical symptoms had reappeared in all patients. This study demonstrated that compliance to nCPAP in OSAS patients is good. No clinical or polysomnographic factors allow to predict non compliance. AHI is not modified by long term treatment with nCPAP.